Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case Report

Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case Report

Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 is characterized by hypercytokinemia leading to overwhelming inflammation. We describe the use of a hemadsorption device as part of the supportive treatment for cytokine storm.

Bibliographic Details
Main Authors: Juan Carlos Ruiz-Rodríguez, Luis Chiscano-Camón, Clara Palmada, Adolf Ruiz-Sanmartin, Marina García-de-Acilu, Erika Plata-Menchaca, Janire Perurena-Prieto, Manuel Hernandez-Gonzalez, Marcos Pérez-Carrasco, Pere Soler-Palacin, Ricard Ferrer
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
hemoadsorption
inflammatory multisystemic syndrome
myocardial injury
cytokine - immunological terms
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.665824/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.665824/full

Similar Items